ArborGen Holdings Limited logo

ArborGen Appoints Justin Birch as Chief Executive Officer

Director Appointment25 April 2023ARBIndustrials

ArborGen Appoints Justin Birch as Chief Executive Officer

25 April 2023

ArborGen Holdings Limited (NZX: ARB) (the Company) is pleased to announce the appointment of

Justin Birch as President and Chief Executive Officer (CEO) of ArborGen Inc. (ArborGen) effective 19

June 2023, or earlier. Mr Birch’s appointment follows a comprehensive and extensive search process.

Mr Birch is an experienced executive with significant exposure to the agriculture sector and a strong

background in private equity, operations, finance, and strategy. He is currently the Chief Financial

Officer of Prima® Wawona in California, an industry leader in the fresh fruit category. Prior to this role,

Mr Birch served in various positions in operations, finance, sales, and strategy at Prima® Wawona as

well as at Materra Farming, an investor-owned farming company. He has also worked for multiple

private equity groups, specialising in the food and agriculture sectors.

Mr Birch will be based at ArborGen’s headquarters in Ridgeville, South Carolina, in the United States.

He will succeed Andrew Baum who will remain as CEO until Mr Birch joins ArborGen, and thereafter

continue in a consulting capacity, to facilitate a seamless leadership transition.

David Knott, Chairman, said "We are delighted to welcome Justin to our company, following a robust

recruitment process. Justin will bring a wealth of commercial experience and excellent operational,

financial and leadership skills to ArborGen. The Board believes he is a great fit for ArborGen, with the

combination of skills and experience to lead the business through its next phase. ArborGen has a

refocused growth strategy with clear and sizeable opportunities. There is positive momentum now in

the business and Justin will continue to build on this and grow ArborGen’s leadership position in the

advanced genetics seedling market.”

Details of Mr Birch’s remuneration arrangements are set out in the attached Appendix. These

arrangements are intended to strongly align his interests with those of shareholders.















Appendix: Details of Remuneration Arrangements

Mr Birch’s remuneration package as President and Chief Executive Officer of ArborGen reflects the

complexity of the role and the wide-ranging skills needed to do it well. It comprises:

▪ A fixed remuneration component comprising cash salary of US$425,000 (Base Salary)

▪ Annual short-term incentive of up to 100% of Base Salary –

▪ Guaranteed for and paid after ArborGen’s fiscal year ended 31 March 2024 comprising:

(i) US$212,500 paid in cash and

(ii) US$212,500 in ARB ordinary shares

▪ For fiscal year ended 31 March 2025 and each fiscal year thereafter – (i) a cash bonus

of up to 50% of then-current Base Salary and (ii) a bonus paid in ARB ordinary shares

of up to 50% of then-current Base Salary, in each case subject to meeting performance

criteria determined by the compensation committee

▪ An equity grant of restricted ordinary shares (Restricted Shares) equal to 4% of ordinary shares

in ARB subject to shareholder approval, as required, comprising:

▪ 50% Time-Based Shares – 50% of such Restricted Shares shall vest as follows: (i) one

third shall vest on the first anniversary of the employment commencement date

(Starting Date); and (ii) two thirds shall vest on the second anniversary of the Starting

Date, in each case subject to completion of continuous service with ArborGen or an

affiliate until the applicable vesting date

▪ 50% Performance-Based Shares – 50% of such Restricted Shares shall vest as follows:

(i) one half of such Performance-Based Shares shall vest on June 1, 2024, and (ii) the

other half of such Performance-Based Shares shall vest on June 1, 2025, in each case

subject to satisfaction of applicable performance criteria determined by the

compensation committee and to completion of continuous service with ArborGen or

an affiliate until the applicable vesting date


ENDS





ArborGen

ArborGen is the largest commercial global seedling supplier and a leading provider of advanced genetics, for the forest

industry. Employing state-of-the-art technology, ArborGen is developing high-value products that significantly improve the

productivity of a given acre of land by enabling our customers to grow trees that yield more wood per acre with greater

consistency and quality in a shorter period of time. For more information, please visit ArborGen’s website at

www.arborgen.com.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • 2CC — 2 Cheap Cars Group Limited: Market update
    2023-04-27

    Mr Guerin is currently CFO of ArchiPro. Prior to that, Gus enjoyed a long and successful international career with British American Tobacco culminating in his role as Director of Finance NZ. He has strong experience in New Zealand and abroad with blue-chip multinational compan…”